Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features

[1]  L. Fishbein,et al.  Pheochromocytoma/Paraganglioma: Review of Perioperative Management of Blood Pressure and Update on Genetic Mutations Associated With Pheochromocytoma , 2013, Journal of clinical hypertension.

[2]  V. Mazzaferro,et al.  Malignant pheochromocytoma and paraganglioma: future considerations for therapy. , 2013, The Quarterly Journal of Nuclear Medicine and Molecular Imaging.

[3]  E. Casiglia,et al.  Gestational diastolic hypertension with gene mutation-related pheochromocytoma positive at ¹⁸F-DOPA PET/CT: diagnostic and therapeutic implications. , 2013, Revista espanola de medicina nuclear e imagen molecular.

[4]  W. Bechstein,et al.  Urapidil in the Preoperative Treatment of Pheochromocytomas: A Safe and Cost-effective Method , 2013, World Journal of Surgery.

[5]  J. Schwartz,et al.  Cost-effectiveness of secondary screening modalities for hypertension , 2013, Blood pressure monitoring.

[6]  M. Biggar,et al.  Systematic review of phaeochromocytoma in pregnancy , 2013, The British journal of surgery.

[7]  G. Doherty,et al.  Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas. , 2012, Surgery.

[8]  J. Trullàs.  [Pseudopheochromocytoma (or when we do not find pheocromocytoma)]. , 2012, Revista clínica española (Ed. impresa).

[9]  Trullàs Jc.  Pseudopheochromocytoma (or when we do not find pheocromocytoma) , 2012 .

[10]  A. Massaro,et al.  18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours , 2012, Nuclear medicine communications.

[11]  J. Lenders,et al.  Pheochromocytoma and pregnancy: a deceptive connection. , 2012, European journal of endocrinology.

[12]  P. Lund-johansen.  Pharmacology of Combined α-β-Blockade II , 1984, Drugs.

[13]  D. Ye,et al.  Analysis of various etiologies of hypertension in patients hospitalized in the endocrinology division , 2012, Endocrine.

[14]  Wesley Mcmillian,et al.  Phentolamine continuous infusion in a patient with pheochromocytoma. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[15]  L. Nieman,et al.  Approach to the patient with an adrenal incidentaloma. , 2010, The Journal of clinical endocrinology and metabolism.

[16]  E. Kaplan,et al.  Pheochromocytoma in Pregnancy: A Case Series and Review , 2010, Hypertension.

[17]  N. Shah,et al.  Pheochromocytoma in children and adolescents , 2009, Indian journal of pediatrics.

[18]  J. Flynn,et al.  Severe hypertension in children and adolescents: pathophysiology and treatment , 2009, Pediatric Nephrology.

[19]  E. Phillips,et al.  Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007. , 2009, The American journal of medicine.

[20]  H. Bridge,et al.  Adrenergic blockade with phenoxybenzamine and propranolol in a cohort of 60 patients undergoing surgery for phaeochromocytoma. , 2008, European journal of anaesthesiology.

[21]  R. Jackson,et al.  Pheochromocytoma in children and adolescents: a clinical spectrum. , 2008, Journal of pediatric surgery.

[22]  S. Mann.  Severe paroxysmal hypertension (Pseudopheochromocytoma) , 2008, Current hypertension reports.

[23]  J. Neutel,et al.  Ambulatory Blood Pressure Monitoring in Clinical Practice , 2007 .

[24]  W. Young,et al.  Pheochromocytoma and Paraganglioma in Children: A Review of Medical and Surgical Management at a Tertiary Care Center , 2006, Pediatrics.

[25]  L. Sibal,et al.  Phaeochromocytomas presenting as acute crises after beta blockade therapy , 2006, Clinical endocrinology.

[26]  E. DeLong,et al.  Detecting Pheochromocytoma: Defining the Most Sensitive Test , 2006, Annals of surgery.

[27]  T. Zelinka,et al.  Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients , 2005, Journal of hypertension.

[28]  J. Tobias,et al.  Presenting Signs and Symptoms of Pheochromocytoma in Pediatric-aged Patients , 2005, Clinical pediatrics.

[29]  G. Lebuffe,et al.  The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas , 2005, Anaesthesia.

[30]  T. Imaizumi,et al.  Pheochromocytoma presenting as recurrent hypotension and syncope. , 2005, Internal medicine.

[31]  D. Vidt,et al.  Hypertensive Crises: Emergencies and Urgencies , 2004, Journal of clinical hypertension.

[32]  M. James,et al.  Pheochromocytoma crisis: the use of magnesium sulfate. , 2004, Anesthesia and analgesia.

[33]  C. Eng,et al.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.

[34]  P. Gosse,et al.  Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. , 2004, British journal of anaesthesia.

[35]  W. Bussmann,et al.  Comparison of nitroglycerin with nifedipine in patients with hypertensive crisis or severe hypertension , 1992, The clinical investigator.

[36]  J. Sack,et al.  Pheochromocytoma and hydralazine-induced myocardial ischaemia in a 14-year-old boy , 1986, European Journal of Pediatrics.

[37]  E. Bravo,et al.  Pheochromocytoma: state-of-the-art and future prospects. , 2003, Endocrine reviews.

[38]  W. White.  Ambulatory blood-pressure monitoring in clinical practice. , 2003, The New England journal of medicine.

[39]  Peter W de Leeuw,et al.  Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. , 2003, The New England journal of medicine.

[40]  M. Culler,et al.  An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro. , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[41]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[42]  E. O’Brien.  Ambulatory blood pressure measurement is indispensable to good clinical practice , 2003, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[43]  Yutaka Imai,et al.  European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement , 2003, Journal of hypertension.

[44]  E. Bravo,et al.  Pheochromocytoma : State-ofthe-Art and Future Prospects , 2003 .

[45]  E. Bravo.  Pheochromocytoma: an approach to antihypertensive management. , 2002, Annals of the New York Academy of Sciences.

[46]  K. Newman,et al.  The Diagnosis and Management of Endocrine Tumors Causing Hypertension in Children , 2002, Annals of the New York Academy of Sciences.

[47]  M. Walther,et al.  Biochemical diagnosis of pheochromocytoma: which test is best? , 2002, JAMA.

[48]  P. Boyle,et al.  Pathophysiology and Treatment , 2000 .

[49]  G. Arnaldi,et al.  Adrenal incidentaloma. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[50]  J. Levy.  TREATMENT OF PERIOPERATIVE HYPERTENSION , 1999 .

[51]  N. Abumrad,et al.  Clinical experience over 48 years with pheochromocytoma. , 1999, Annals of surgery.

[52]  Y. Imai,et al.  Altered sympathetic and vagal modulations of the cardiovascular system in patients with pheochromocytoma: their relations to orthostatic hypotension. , 1999, American journal of hypertension.

[53]  R. Dluhy.  Uncommon forms of secondary hypertension in older patients. , 1998, American journal of hypertension.

[54]  P. Kowey,et al.  Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? , 1996, JAMA.

[55]  A. Pessina,et al.  [Hypertension secondary to multiple malignant paragangliomas]. , 1996, Giornale italiano di cardiologia.

[56]  Richard W. Schwartz,et al.  Diagnosis and management of adrenal tumors. , 1996, Current Opinion in Oncology.

[57]  J. Wallin,et al.  Labetalol and other agents that block both alpha- and beta-adrenergic receptors. , 1994, Cleveland Clinic journal of medicine.

[58]  D. London,et al.  Phaeochromocytomas as a cause of hypotension , 1992, Clinical endocrinology.

[59]  G. Mcinnes,et al.  Use of Beta-Blockade in a Patient with Phaeochromocytoma and Asthma , 1992, Scottish Medical Journal.

[60]  M. Molitch.  10 Endocrine emergencies in pregnancy , 1992 .

[61]  D. Goldstein,et al.  Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. , 1987, The New England journal of medicine.

[62]  D. Taylor-Robinson.  Future considerations: therapy , 1986 .

[63]  E. Baldi,et al.  Effect of verapamil on catecholamine secretion by human pheochromocytoma. , 1986, Hypertension.

[64]  M. Deswiet.  Antihypertensive drugs in pregnancy. , 1985, British medical journal.

[65]  G. Stenström,et al.  PHEOCHROMOCYTOMA IN PREGNANCY , 1985, Acta obstetricia et gynecologica Scandinavica.

[66]  K. Swolin,et al.  CASE REPORT PHEOCHROMOCYTOMA IN PREGNANCY Experience of treatment with phenoxybenzamine in three patients , 1985 .

[67]  M. Weinberger,et al.  Rapid cyclic fluctuations of blood pressure associated with an adrenal pheochromocytoma. , 1984, Hypertension.

[68]  P. Lund-johansen.  Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol. , 1984, Drugs.

[69]  J. Laragh,et al.  Pheochromocytoma and prazosin. , 1983, Annals of internal medicine.

[70]  S. Sheps,et al.  Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. , 1981, Mayo Clinic proceedings.

[71]  Z. B. Barnes.  A safe and cost effective method of colon resection. , 1981, Journal of the Medical Association of the State of Alabama.

[72]  C. Lowy.  Endocrine emergencies in pregnancy. , 1980, Clinics in endocrinology and metabolism.

[73]  C. Feek,et al.  Hypertensive response to labetalol in phaeochromocytoma. , 1980, British medical journal.

[74]  M. Hojo,et al.  DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS , 1978 .

[75]  J. Pohl,et al.  HYPERTENSIVE RESPONSE TO LABETALOL IN PHÆOCHROMOCYTOMA , 1978, The Lancet.

[76]  G. Phillips.  Oestrogens in ischaemic heart-disease. , 1976, Lancet.

[77]  B. Hamrin.  Sustained hypotension and shock due to an adrenaline-secreting phaeochromocytoma. , 1962, Lancet.

[78]  S. Frazer,et al.  Paroxysmal hypotension due to an adrenaline-secreting phaeochromocytoma. , 1961, Lancet.